Cargando…
Lessons from CDER’s Quality Management Maturity Pilot Programs
Between October 2020 and March 2022, FDA’s Center for Drug Evaluation and Research (CDER) completed two pilot programs to assess the quality management maturity (QMM) of drug manufacturing establishments. Mature quality systems promote proactive detection of vulnerabilities, prevent problems before...
Autores principales: | Maguire, Jennifer, Fisher, Adam, Harouaka, Djamila, Rakala, Nandini, Lundi, Carla, Yambot, Marcus, Viehmann, Alex, Stiber, Neil, Gonzalez, Kevin, Canida, Lyle, Buhse, Lucinda, Kopcha, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831683/ https://www.ncbi.nlm.nih.gov/pubmed/36627496 http://dx.doi.org/10.1208/s12248-022-00777-z |
Ejemplares similares
-
Quality Testing of Difficult-to-Make Prescription Pharmaceutical Products Marketed in the US
por: Fisher, Adam C., et al.
Publicado: (2020) -
Benchmarking the Quality Practices of Global Pharmaceutical Manufacturing to Advance Supply Chain Resilience
por: Fellows, Matt, et al.
Publicado: (2022) -
Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER
por: Ionan, Alexei C., et al.
Publicado: (2022) -
Workgroup Report: Review of Genomics Data Based on Experience with Mock Submissions—View of the CDER Pharmacology Toxicology Nonclinical Pharmacogenomics Subcommittee
por: Leighton, John K., et al.
Publicado: (2006) -
Infections Diseases in the Context of Terrorist Threat
por: Andreychyn, M., et al.
Publicado: (2009)